The V Foundation for Cancer Research, founded by legendary basketball coach Jim Valvano, currently has funding opportunities to support translational research projects within the scope of adult cancer research. Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than three years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.
The Translational Research Award is a $600,000 grant paid in three annual installments of $200,000. Indirect costs up to 10% are permitted (i.e., over the grant term, a maximum of $60,000 can be utilized for indirect costs, leaving $540,000 for direct costs).
Nominations are due to Farah Mirza (email@example.com) by 5 p.m. EST on April 16.
Applications are due by 5 p.m. on May 28.